NCT02877160 A Study to Assess the PK of AL-794 Formulations in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02876159 The Immunologic Basis for an Attenuated Immune Response to the Influenza Vaccine After Repeated Annual Vaccination Status COMPLETED Phase PHASE4
NCT02871206 Adjuvanted Inactivated Vaccine Versus Inactivated Influenza Vaccine in Hutterite Children Status COMPLETED Phase PHASE4
NCT02860039 High Dose Flu Vaccine in Treating Children Who Have Undergone Donor Stem Cell Transplant Status COMPLETED Phase PHASE2
NCT02846311 Evaluation of the Alere i Influenza A&B Nucleic Acid Amplification Versus Xpert Flu/RSV Status COMPLETED Phase N/A
NCT02819180 Study to Evaluate Safety and Immunogenicity of Butantan Seasonal Influenza Vaccine - FLU-02-IB Status COMPLETED Phase N/A
NCT02819115 Cohort Study to Evaluate Safety and Immunogenicity of Butantan Seasonal Influenza Vaccine Status COMPLETED Phase N/A
NCT02762851 Influenza Vaccine To Prevent Adverse Vascular Events (RCT-IVVE) Status UNKNOWN Phase PHASE4
NCT02743676 A Retrospective, Observational Registry of Participants With Avian Influenza Infection Status COMPLETED Phase N/A
NCT02743117 Study to Evaluate the Safety of 1 New 6:2 Influenza Virus Reassortant in Adults for the 2016-2017 Season Status COMPLETED Phase PHASE4
NCT02719743 A Dose Ranging Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' GSK1557484A Vaccine in Children 6 to Less Than 36 Months of Age Status COMPLETED Phase PHASE2
NCT02710409 A Phase III Clinical Trial of An Inactivated Quadrivalent Influenza Vaccine in Healthy Subjects Aged 3 Years and Older Status COMPLETED Phase PHASE3
NCT02691130 Assess the Safety and Immunogenicity of M-001 as A Standalone Influenza Vaccine and as A H5N1 Vaccine Primer in Adults Status COMPLETED Phase PHASE2
NCT02686398 Immunogenicity of a Trivalent Influenza Vaccine in Chronic Kidney Disease Patients Undergoing Hemodialysis Status COMPLETED Phase PHASE4
NCT02677493 Study to Evaluate the Immunogenicity and Safety of 'IL-YANG Quadrivalent Influenza Vaccine Inj.' Status COMPLETED Phase PHASE3
NCT02665871 Safety Study of Freeze-dried Live Attenuated Influenza Vaccine for Intranasal Administration in Chinese Adults Aged 3 Years and Older Status UNKNOWN Phase PHASE1
NCT02665351 Peramivir Treatment Response in Adults Hospitalized for Influenza-associated Lower Respiratory Tract Infections Status COMPLETED Phase PHASE2/PHASE3